The FDA is advising people with diabetes and health care professionals to stop using GenStrip Blood Glucose Test Strips because the strips may report incorrect blood glucose levels.
Category: Products & Tech
DiabetesMine has announced the launch of a video product review hub, dubbed the Test Kitchen, created specifically by and for people whose lives are affected by diabetes.
In 2003, an MIT chemical engineer founded a company called SmartCells, to develop smart insulin.
Smart insulin is a form of insulin that circulates in the bloodstream and turns on when it’s needed to lower blood sugars and off when blood sugars are at safe levels.
Like many other people with diabetes, I had a complicated reaction to the recent story in the New York Times, “Even Small Medical Advances Can Mean Big Jumps in Bills,” by Elisabeth Rosenthal about the high costs of diabetes care in the United States. At first, I was excited: Type 1 diabetes above the fold?
The U.S. FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 13 to 1 to recommend that Afrezza (insulin human [rDNA origin]) Inhalation Powder be granted marketing approval by the FDA
We in the diabetes community need to speak out to argue that a. insulin pumps should be removed from competitive bidding and b. that if they remain in the competitive bidding program, CMS must use a different process to determine reimbursement rates, so that cost-saving does not stifle innovation.
Whether you’re used to a slow priming device or a relatively quick one, you’ve never seen one quite as fast as the Asante Snap. As soon as you twist the cartridge cap on, insulin appears at the end of the introducer needle. The innovative cartridge cap that auto-primes the tubing also contains additional occlusion detection rather than relying solely on back pressure like other pumps.
Abbott Diabetes Care has issued a recall for the FreeStyle Blood Glucose Meter and the FreeStyle Flash Blood Glucose Meter. The recall was issued after the company discovered that FreeStyle Flash® and FreeStyle® Blood Glucose Meters may produce mistakenly low blood glucose results when using...
The FDA has issued a complete response letter to Boehringer Ingelheim and Eli Lilly for the New Drug Application (NDA) of the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin.
The complete response letter referenced previously observed deficiencies at a Boehringer Ingelheim facility where empagliflozin will be manufactured.
Enter every pumper's least welcome buddy - the air bubble. Your insulin pump (regardless of make or model) cannot elegantly handle the pressure changes during ascent and descent and is moving air bubbles and insulin into your body without ever recording evidence of it.